Treatment of Low Energy, Motivation, and Mood in Perimenopause with ADHD Traits
Introduction to Bupropion Treatment
- The American Academy of Child and Adolescent Psychiatry recommends bupropion as a second-line option when stimulants are contraindicated or not tolerated, which directly applies to this case 1
- Bupropion is the only antidepressant consistently shown to promote weight loss and has proven efficacy for both depression and ADHD symptoms, making it ideal for this clinical presentation where stimulants cannot be used 2
- Bupropion is a norepinephrine and dopamine reuptake inhibitor that has been shown to be more effective than placebo in adults with ADHD 3
- For patients with ADHD and comorbid depressive symptoms where stimulants are not an option, bupropion effectively addresses both conditions simultaneously 1, 4
Dosing and Monitoring
- Start with bupropion SR 100-150 mg daily or XL at 150 mg daily 1
- Titrate to maintenance doses of 100-150 mg twice daily (SR) or 150-300 mg daily (XL) 1
- Maximum recommended dose is 450 mg per day 1
- Unlike stimulants which work within days, bupropion requires 2-4 weeks to achieve full therapeutic effect, so set appropriate expectations with the patient 1
- Screen for suicidality, particularly given the comorbid depressive symptoms and caregiver stress 2
- Monitor for common side effects including headache, insomnia, and anxiety, especially during the first 2-4 weeks 1, 2
Managing Side Effects and Alternative Options
- For insomnia, consider low-dose trazodone or non-pharmacological interventions like sleep hygiene education and cognitive behavioral therapy 2
- If anxiety worsens despite no baseline anxiety, consider adjunctive treatments like buspirone augmentation or mindfulness-based stress reduction techniques 2
- Atomoxetine (60-100 mg daily) is the only FDA-approved non-stimulant for adult ADHD, though it requires 2-4 weeks to achieve full effect and carries a black box warning for suicidal ideation requiring close monitoring 1
- Alpha-2 agonists (guanfacine 1-4 mg daily or clonidine) are additional options with 2-4 weeks until effects are observed, particularly useful if sleep disturbances emerge 1
- Viloxazine is a newer non-stimulant option that has shown significant efficacy in treating ADHD in adults 3, 2
Augmentation and Treatment Duration
- If ADHD-related symptoms improve with bupropion but depressive symptoms persist after 4-6 weeks, add an SSRI to the regimen, as there are no significant drug-drug interactions between bupropion and SSRIs 1
- SSRIs remain the treatment of choice for depression and are weight-neutral with long-term use 1
- Continue antidepressant treatment for 4-9 months after achieving satisfactory response in a first episode of major depression, with longer duration for patients with recurrent episodes 4
Safety Considerations
- Never use MAO inhibitors concurrently with bupropion due to risk of hypertensive crisis - at least 14 days should elapse between discontinuation of an MAOI and initiation of bupropion 1
- The combination of bupropion with any future stimulant therapy (if contraindication resolves) may increase the risk of seizures, particularly at higher doses of bupropion 1
- Avoid benzodiazepines for any emerging anxiety, as they may reduce self-control and have disinhibiting effects 1
Adjunctive Non-Pharmacological Interventions
- Dialectical Behavior Therapy (DBT) has been modified for adult patients with ADHD and shows decreased ADHD symptoms, improved neuropsychological functioning, and reduction of co-existing anxiety and depression 3
- The four DBT modules address: mindfulness skills, distress tolerance, interpersonal effectiveness, and emotion regulation 3
- Mindfulness interventions during this life transition may improve self-compassion and various dimensions of mindfulness 3